BDBM192297 US10526329, Compound 101::US11072611, Compound 101::US9670204, 101 N-(2-ethyl-6-(1-(methylsulfonyl)piperidin-4-yl)imidazo[1,2-a]pyridin-3-yl)-4-(4-fluorophenyl)-N,5-dimethylthiazol-2-amine::US9670204, 102 4-(4-fluorophenyl)-N-(2-ethyl-6-(1-(methylsulfonyl)piperidin-4-yl)imidazo[1,2-a]pyridin-3-yl)-N-(d3-methyl)thiazol-2-amine::US9670204, 103 4-(4-fluorophenyl)-N-(2-ethyl-6-(1-(methylsulfonyl)piperidin-4-yl)imidazo[1,2-a]pyridin-3-yl)-N-(d3-methyl)(d-thiazol-2)-amine

SMILES CCc1nc2ccc(cn2c1N(C)c1nc(c(C)s1)-c1ccc(F)cc1)C1CCN(CC1)S(C)(=O)=O

InChI Key InChIKey=FULDSPKQUPKPFG-UHFFFAOYSA-N

Data  10 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 10 hits for monomerid = 192297   

TargetAutotaxin(Human)
Galapagos

US Patent
LigandPNGBDBM192297(US9670204, 103 4-(4-fluorophenyl)-N-(2-ethyl-6-(1-...)
Affinity DataIC50: 1.00E+3nMpH: 8.5 T: 2°CAssay Description:Compound IC50 values are determined in a hENPP2 (UniProtKB/SwissProt Sequence ref Q13822) biochemical assay using LPC as substrate. 5 μL of a di...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/7/2018
Entry Details
Go to US Patent

TargetAutotaxin(Human)
Galapagos

US Patent
LigandPNGBDBM192297(US9670204, 103 4-(4-fluorophenyl)-N-(2-ethyl-6-(1-...)
Affinity DataIC50: 1.00E+3nMpH: 8.5 T: 2°CAssay Description:Compound IC50 values are determined in a hENPP2 (UniProtKB/SwissProt Sequence ref Q13822) biochemical assay using LPC as substrate. 5 μL of a di...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/7/2018
Entry Details
Go to US Patent

TargetAutotaxin(Human)
Galapagos

US Patent
LigandPNGBDBM192297(US9670204, 103 4-(4-fluorophenyl)-N-(2-ethyl-6-(1-...)
Affinity DataIC50: 300nMpH: 8.5 T: 2°CAssay Description:Compound IC50 values are determined in a hENPP2 (UniProtKB/SwissProt Sequence ref Q13822) biochemical assay using LPC as substrate. 5 μL of a di...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/7/2018
Entry Details
Go to US Patent

TargetAutotaxin(Human)
Galapagos

US Patent
LigandPNGBDBM192297(US9670204, 103 4-(4-fluorophenyl)-N-(2-ethyl-6-(1-...)
Affinity DataIC50: 2.27E+3nMAssay Description:Inhibition of glycosylated human ATX using LPC 16:0 as substrate after 30 mins by luminescence assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/24/2019
Entry Details Article
PubMed
TargetAutotaxin(Human)
Galapagos

US Patent
LigandPNGBDBM192297(US9670204, 103 4-(4-fluorophenyl)-N-(2-ethyl-6-(1-...)
Affinity DataIC50: 1.00E+3nMAssay Description:Compound IC50 values are determined in a hENPP2 (UniProtKB/SwissProt Sequence ref Q13822) biochemical assay using LPC as substrate.5 μL of a dil...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/25/2020
Entry Details
Go to US Patent

TargetAutotaxin(Human)
Galapagos

US Patent
LigandPNGBDBM192297(US9670204, 103 4-(4-fluorophenyl)-N-(2-ethyl-6-(1-...)
Affinity DataIC50: 300nMAssay Description:Compound IC50 values are determined in a hENPP2 (UniProtKB/SwissProt Sequence ref Q13822) biochemical assay using LPC as substrate.5 μL of a dil...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/25/2020
Entry Details
Go to US Patent

TargetAutotaxin(Human)
Galapagos

US Patent
LigandPNGBDBM192297(US9670204, 103 4-(4-fluorophenyl)-N-(2-ethyl-6-(1-...)
Affinity DataIC50: 50nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
10/25/2020
Entry Details
Go to US Patent

TargetAutotaxin(Human)
Galapagos

US Patent
LigandPNGBDBM192297(US9670204, 103 4-(4-fluorophenyl)-N-(2-ethyl-6-(1-...)
Affinity DataIC50: 50nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
10/25/2020
Entry Details
Go to US Patent

TargetAutotaxin(Human)
Galapagos

US Patent
LigandPNGBDBM192297(US9670204, 103 4-(4-fluorophenyl)-N-(2-ethyl-6-(1-...)
Affinity DataIC50: 1.00E+3nMAssay Description:TABLE V: 5 μL of a dilution series of compound, starting from 20 μM highest concentration, 1/5 dilution, is added to the wells. hENPP2 is u...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/7/2022
Entry Details
Go to US Patent

TargetAutotaxin(Human)
Galapagos

US Patent
LigandPNGBDBM192297(US9670204, 103 4-(4-fluorophenyl)-N-(2-ethyl-6-(1-...)
Affinity DataIC50: 50nMAssay Description:TABLE VI: (UniProtKB/SwissProt Sequence ref Q13822) biochemical assay using the fluorogenic autotaxin substrate FS-3 as substrate. FS-3 is a doubly l...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/7/2022
Entry Details
Go to US Patent